To demonstrate the ability of this newly established system to identify condition-specific phosphorylated proteins in cultured cells, we first asked whether the downstream mediators known to be phosphorylated upon activation of HGF/c-Met signaling could be detected using a well-characterized human glioma cell line. The gene discussed is MET; the disease is central nervous system cancer.